Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Blondel

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Biotechnology Journal|August 8, 2006
Using budding yeast to screen for anti-prion drugsDéborah Tribouillard, Stéphane Bach, Fabienne Gug, et al.
Human Molecular Genetics|January 17, 2019
Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1aDamien Marechal, Véronique Brault, Alice Leon, et al.
Nucleic Acids Research|October 9, 2023
Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNARonan Le Sénéchal, Marc Keruzoré, Alicia Quillévéré, et al.
Nucleic Acids Research|July 4, 2025
The Epstein-Barr virus EBNA1 protein binds to G-quadruplexes in its own mRNA hence controlling its expression and immune evasion of the virusVan-Trang Dinh, Nadège Loaëc, Alicia Quillévéré, et al.
Scientific Reports|September 17, 2016
Protein Folding Activity of the Ribosome is involved in Yeast Prion PropagationMarc Blondel, Flavie Soubigou, Justine Evrard, et al.
ACS Chemical Neuroscience|September 23, 2014
Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activityPhu Hai Nguyen, Hassan Hammoud, Sophie Halliez, et al.
Nucleic Acids Research|November 9, 2022
Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune systemGaelle Angrand, Alicia Quillévéré, Nadège Loaëc, et al.
Nucleic Acids Research|September 15, 2022
The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNAAlice J L Zheng, Aikaterini Thermou, Chrysoula Daskalogianni, et al.
Life Science Alliance|November 17, 2021
The different activities of RNA G-quadruplex structures are controlled by flanking sequencesAlice J-L Zheng, Aikaterini Thermou, Pedro Guixens Gallardo, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 29, 2020
Artemisinin and its derivatives target mitochondrial c-type cytochromes in yeast and human cellsAnais Laleve, Cristina Panozzo, Inge Kühl, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Biotechnology Journal|August 8, 2006
Using budding yeast to screen for anti-prion drugsDéborah Tribouillard, Stéphane Bach, Fabienne Gug, et al.
Human Molecular Genetics|January 17, 2019
Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1aDamien Marechal, Véronique Brault, Alice Leon, et al.
Nucleic Acids Research|October 9, 2023
Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNARonan Le Sénéchal, Marc Keruzoré, Alicia Quillévéré, et al.
Nucleic Acids Research|July 4, 2025
The Epstein-Barr virus EBNA1 protein binds to G-quadruplexes in its own mRNA hence controlling its expression and immune evasion of the virusVan-Trang Dinh, Nadège Loaëc, Alicia Quillévéré, et al.
Scientific Reports|September 17, 2016
Protein Folding Activity of the Ribosome is involved in Yeast Prion PropagationMarc Blondel, Flavie Soubigou, Justine Evrard, et al.
ACS Chemical Neuroscience|September 23, 2014
Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activityPhu Hai Nguyen, Hassan Hammoud, Sophie Halliez, et al.
Nucleic Acids Research|November 9, 2022
Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune systemGaelle Angrand, Alicia Quillévéré, Nadège Loaëc, et al.
Nucleic Acids Research|September 15, 2022
The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNAAlice J L Zheng, Aikaterini Thermou, Chrysoula Daskalogianni, et al.
Life Science Alliance|November 17, 2021
The different activities of RNA G-quadruplex structures are controlled by flanking sequencesAlice J-L Zheng, Aikaterini Thermou, Pedro Guixens Gallardo, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 29, 2020
Artemisinin and its derivatives target mitochondrial c-type cytochromes in yeast and human cellsAnais Laleve, Cristina Panozzo, Inge Kühl, et al.
Pageof 8